心脏诊断下降1为30反向股票分割

2025-05-08 20:48

Cardio Diagnostics (NASDAQ:CDIO) announced on Thursday, a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.
The reverse stock split is part of the company’s plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
As a result of the reverse stock split, every 30 shares of the company’s common stock issued and outstanding prior to the opening of trading on May 13, 2025, will be combined into one issued and outstanding share, with no change in the nominal par value per share of $0.00001.
As a result of the reverse stock split, the number of shares of common stock outstanding will be reduced from approximately 52M shares to approximately 1.7M shares, and the number of authorized shares of common stock will remain at 300M shares.
Cardio Diagnostics (NASDAQ:CDIO) shares were down more than 40% in pre-market trading.

More on Cardio Diagnostics Holdings, Inc.